← FDA DRUG APPROVALS

FDA ANDA · ANDA077214

ZOLPIDEM

zolpidem tartrate

Sponsor: ACME LABS

APPLICATION
ANDA077214
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-23
LATEST ACTION
2022-11-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 5MG · TABLET · ORAL
ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 10MG · TABLET · ORAL

Approval history

2022-11-17Labeling · Supplement 8 · standardAP
2015-06-01Labeling · Supplement 6 · standardAP
2013-09-18Labeling · Supplement 5 · standardAP
2010-08-16Labeling · Supplement 3AP
2008-09-03Labeling · Supplement 2AP
2008-05-29Labeling · Supplement 1AP
2007-04-23OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →